RAPAMUNE 0.5 mg, coated tablet 30 tablets
Active ingredients: Sirolimus
Commercialized according to BDPMDispensing in France: Prescription only
Coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RAPAMUNE 0,5 mg, comprimé enrobé
- Pharmaceutical form
- comprimé enrobé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC polyéthylène aluminium-ACLAR de 30 comprimé(s)
- Marketing authorisation holder
- PFIZER EUROPE MA EEIG (BELGIQUE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 7 Jun 2011
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69171174CIP74930457CIP133400949304578Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SIROLIMUScomprimé | 0,50 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.